Global Anti-inflammatory Therapeutics Market 2017 - Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022

 Buy Now

   Published Date : Jul-2017   |    Format : PDF   |    Pages : 100
This report studies Anti-inflammatory Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    AbbVie Inc.
    Pfizer Inc.
    Merck & Co., Inc.
    Johnson & Johnson
    GlaxoSmithKline plc
    AstraZeneca PLC
    Amgen Inc
    Novartis AG
    F. Hoffmann-La Roche AG
    Eli Lily and Company

By types, the market can be split into
    Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
    Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    Corticosteroids
    Biologics

By Application, the market can be split into
    Arthritis
    Psoriasis
    Respiratory Disease
    Multiple Sclerosis
    Inflammatory Bowel Disease
    Other Inflammatory Disease

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Anti-inflammatory Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Anti-inflammatory Therapeutics
    1.1 Definition and Specifications of Anti-inflammatory Therapeutics
        1.1.1 Definition of Anti-inflammatory Therapeutics
        1.1.2 Specifications of Anti-inflammatory Therapeutics
    1.2 Classification of Anti-inflammatory Therapeutics
        1.2.1 Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
        1.2.2 Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
        1.2.3 Corticosteroids
        1.2.4 Biologics
    1.3 Applications of Anti-inflammatory Therapeutics
        1.3.1 Arthritis
        1.3.2 Psoriasis
        1.3.3 Respiratory Disease
        1.3.4 Multiple Sclerosis
        1.3.5 Inflammatory Bowel Disease
        1.3.6 Other Inflammatory Disease
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Anti-inflammatory Therapeutics
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Anti-inflammatory Therapeutics
    2.3 Manufacturing Process Analysis of Anti-inflammatory Therapeutics
    2.4 Industry Chain Structure of Anti-inflammatory Therapeutics

3 Technical Data and Manufacturing Plants Analysis of Anti-inflammatory Therapeutics
    3.1 Capacity and Commercial Production Date of Global Anti-inflammatory Therapeutics Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Anti-inflammatory Therapeutics Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Anti-inflammatory Therapeutics Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Anti-inflammatory Therapeutics Major Manufacturers in 2016

4 Global Anti-inflammatory Therapeutics Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Anti-inflammatory Therapeutics Capacity and Growth Rate Analysis
        4.2.2 2016 Anti-inflammatory Therapeutics Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Anti-inflammatory Therapeutics Sales and Growth Rate Analysis
        4.3.2 2016 Anti-inflammatory Therapeutics Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Anti-inflammatory Therapeutics Sales Price
        4.4.2 2016 Anti-inflammatory Therapeutics Sales Price Analysis (Company Segment)

5 Anti-inflammatory Therapeutics Regional Market Analysis
    5.1 North America Anti-inflammatory Therapeutics Market Analysis
        5.1.1 North America Anti-inflammatory Therapeutics Market Overview
        5.1.2 North America 2012-2017E Anti-inflammatory Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Anti-inflammatory Therapeutics Sales Price Analysis
        5.1.4 North America 2016 Anti-inflammatory Therapeutics Market Share Analysis
    5.2 China Anti-inflammatory Therapeutics Market Analysis
        5.2.1 China Anti-inflammatory Therapeutics Market Overview
        5.2.2 China 2012-2017E Anti-inflammatory Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Anti-inflammatory Therapeutics Sales Price Analysis
        5.2.4 China 2016 Anti-inflammatory Therapeutics Market Share Analysis
    5.3 Europe Anti-inflammatory Therapeutics Market Analysis
        5.3.1 Europe Anti-inflammatory Therapeutics Market Overview
        5.3.2 Europe 2012-2017E Anti-inflammatory Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Anti-inflammatory Therapeutics Sales Price Analysis
        5.3.4 Europe 2016 Anti-inflammatory Therapeutics Market Share Analysis
    5.4 Southeast Asia Anti-inflammatory Therapeutics Market Analysis
        5.4.1 Southeast Asia Anti-inflammatory Therapeutics Market Overview
        5.4.2 Southeast Asia 2012-2017E Anti-inflammatory Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Anti-inflammatory Therapeutics Sales Price Analysis
        5.4.4 Southeast Asia 2016 Anti-inflammatory Therapeutics Market Share Analysis
    5.5 Japan Anti-inflammatory Therapeutics Market Analysis
        5.5.1 Japan Anti-inflammatory Therapeutics Market Overview
        5.5.2 Japan 2012-2017E Anti-inflammatory Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Anti-inflammatory Therapeutics Sales Price Analysis
        5.5.4 Japan 2016 Anti-inflammatory Therapeutics Market Share Analysis
    5.6 India Anti-inflammatory Therapeutics Market Analysis
        5.6.1 India Anti-inflammatory Therapeutics Market Overview
        5.6.2 India 2012-2017E Anti-inflammatory Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Anti-inflammatory Therapeutics Sales Price Analysis
        5.6.4 India 2016 Anti-inflammatory Therapeutics Market Share Analysis

6 Global 2012-2017E Anti-inflammatory Therapeutics Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Anti-inflammatory Therapeutics Sales by Type
    6.2 Different Types of Anti-inflammatory Therapeutics Product Interview Price Analysis
    6.3 Different Types of Anti-inflammatory Therapeutics Product Driving Factors Analysis
        6.3.1 Nonsteroidal Anti-inflammatory Diseases (NSAIDs) of Anti-inflammatory Therapeutics Growth Driving Factor Analysis
        6.3.2 Immune Selective Anti-inflammatory Derivatives (ImSAIDs) of Anti-inflammatory Therapeutics Growth Driving Factor Analysis
        6.3.3 Corticosteroids of Anti-inflammatory Therapeutics Growth Driving Factor Analysis
        6.3.4 Biologics of Anti-inflammatory Therapeutics Growth Driving Factor Analysis

7 Global 2012-2017E Anti-inflammatory Therapeutics Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Anti-inflammatory Therapeutics Consumption by Application
    7.2 Different Application of Anti-inflammatory Therapeutics Product Interview Price Analysis
    7.3 Different Application of Anti-inflammatory Therapeutics Product Driving Factors Analysis
        7.3.1 Arthritis of Anti-inflammatory Therapeutics Growth Driving Factor Analysis
        7.3.2 Psoriasis of Anti-inflammatory Therapeutics Growth Driving Factor Analysis
        7.3.3 Respiratory Disease of Anti-inflammatory Therapeutics Growth Driving Factor Analysis
        7.3.4 Multiple Sclerosis of Anti-inflammatory Therapeutics Growth Driving Factor Analysis
        7.3.5 Inflammatory Bowel Disease of Anti-inflammatory Therapeutics Growth Driving Factor Analysis
        7.3.6 Other Inflammatory Disease of Anti-inflammatory Therapeutics Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Anti-inflammatory Therapeutics
    8.1 AbbVie Inc.
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 AbbVie Inc. 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 AbbVie Inc. 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis
    8.2 Pfizer Inc.
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Pfizer Inc. 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Pfizer Inc. 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis
    8.3 Merck & Co., Inc.
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Merck & Co., Inc. 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Merck & Co., Inc. 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis
    8.4 Johnson & Johnson
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Johnson & Johnson 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Johnson & Johnson 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis
    8.5 GlaxoSmithKline plc
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 GlaxoSmithKline plc 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 GlaxoSmithKline plc 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis
    8.6 AstraZeneca PLC
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 AstraZeneca PLC 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 AstraZeneca PLC 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis
    8.7 Amgen Inc
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Amgen Inc 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Amgen Inc 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis
    8.8 Novartis AG
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Novartis AG 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Novartis AG 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis
    8.9 F. Hoffmann-La Roche AG
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 F. Hoffmann-La Roche AG 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 F. Hoffmann-La Roche AG 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis
    8.10 Eli Lily and Company
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Eli Lily and Company 2016 Anti-inflammatory Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Eli Lily and Company 2016 Anti-inflammatory Therapeutics Business Region Distribution Analysis

9 Development Trend of Analysis of Anti-inflammatory Therapeutics Market
    9.1 Global Anti-inflammatory Therapeutics Market Trend Analysis
        9.1.1 Global 2017-2022 Anti-inflammatory Therapeutics Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Anti-inflammatory Therapeutics Sales Price Forecast
    9.2 Anti-inflammatory Therapeutics Regional Market Trend
        9.2.1 North America 2017-2022 Anti-inflammatory Therapeutics Consumption Forecast
        9.2.2 China 2017-2022 Anti-inflammatory Therapeutics Consumption Forecast
        9.2.3 Europe 2017-2022 Anti-inflammatory Therapeutics Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Anti-inflammatory Therapeutics Consumption Forecast
        9.2.5 Japan 2017-2022 Anti-inflammatory Therapeutics Consumption Forecast
        9.2.6 India 2017-2022 Anti-inflammatory Therapeutics Consumption Forecast
    9.3 Anti-inflammatory Therapeutics Market Trend (Product Type)
    9.4 Anti-inflammatory Therapeutics Market Trend (Application)

10 Anti-inflammatory Therapeutics Marketing Type Analysis
    10.1 Anti-inflammatory Therapeutics Regional Marketing Type Analysis
    10.2 Anti-inflammatory Therapeutics International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Anti-inflammatory Therapeutics by Region
    10.4 Anti-inflammatory Therapeutics Supply Chain Analysis

11 Consumers Analysis of Anti-inflammatory Therapeutics
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
    …

12 Conclusion of the Global Anti-inflammatory Therapeutics Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures
    Figure Picture of Anti-inflammatory Therapeutics
    Table Product Specifications of Anti-inflammatory Therapeutics
    Table Classification of Anti-inflammatory Therapeutics
    Figure Global Production Market Share of Anti-inflammatory Therapeutics by Type in 2016
    Figure Nonsteroidal Anti-inflammatory Diseases (NSAIDs) Picture
    Table Major Manufacturers of Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
    Figure Immune Selective Anti-inflammatory Derivatives (ImSAIDs) Picture
    Table Major Manufacturers of Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
    Figure Corticosteroids Picture
    Table Major Manufacturers of Corticosteroids
    Figure Biologics Picture
    Table Major Manufacturers of Biologics
    Table Applications of Anti-inflammatory Therapeutics
    Figure Global Consumption Volume Market Share of Anti-inflammatory Therapeutics by Application in 2016
    Figure Arthritis Examples
    Table Major Consumers in Arthritis
    Figure Psoriasis Examples
    Table Major Consumers in Psoriasis
    Figure Respiratory Disease Examples
    Table Major Consumers in Respiratory Disease
    Figure Multiple Sclerosis Examples
    Table Major Consumers in Multiple Sclerosis
    Figure Inflammatory Bowel Disease Examples
    Table Major Consumers in Inflammatory Bowel Disease
    Figure Other Inflammatory Disease Examples
    Table Major Consumers in Other Inflammatory Disease
    Figure Market Share of Anti-inflammatory Therapeutics by Regions
    Figure North America Anti-inflammatory Therapeutics Market Size (Million USD) (2012-2022)
    Figure China Anti-inflammatory Therapeutics Market Size (Million USD) (2012-2022)
    Figure Europe Anti-inflammatory Therapeutics Market Size (Million USD) (2012-2022)
    Figure Southeast Asia Anti-inflammatory Therapeutics Market Size (Million USD) (2012-2022)
    Figure Japan Anti-inflammatory Therapeutics Market Size (Million USD) (2012-2022)
    Figure India Anti-inflammatory Therapeutics Market Size (Million USD) (2012-2022)
    Table Anti-inflammatory Therapeutics Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Anti-inflammatory Therapeutics in 2016
    Figure Manufacturing Process Analysis of Anti-inflammatory Therapeutics
    Figure Industry Chain Structure of Anti-inflammatory Therapeutics
    Table Capacity and Commercial Production Date of Global Anti-inflammatory Therapeutics Major Manufacturers in 2016
    Table Manufacturing Plants Distribution of Global Anti-inflammatory Therapeutics Major Manufacturers in 2016
    Table R&D Status and Technology Source of Global Anti-inflammatory Therapeutics Major Manufacturers in 2016
    Table Raw Materials Sources Analysis of Global Anti-inflammatory Therapeutics Major Manufacturers in 2016
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Anti-inflammatory Therapeutics 2012-2017
    Figure Global 2012-2017E Anti-inflammatory Therapeutics Market Size (Volume) and Growth Rate
    Figure Global 2012-2017E Anti-inflammatory Therapeutics Market Size (Value) and Growth Rate
    Table 2012-2017E Global Anti-inflammatory Therapeutics Capacity and Growth Rate
    Table 2016 Global Anti-inflammatory Therapeutics Capacity (K MT) List (Company Segment)
    Table 2012-2017E Global Anti-inflammatory Therapeutics Sales (K MT) and Growth Rate
    Table 2016 Global Anti-inflammatory Therapeutics Sales (K MT) List (Company Segment)
    Table 2012-2017E Global Anti-inflammatory Therapeutics Sales Price (USD/MT)
    Table 2016 Global Anti-inflammatory Therapeutics Sales Price (USD/MT) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K MT) of Anti-inflammatory Therapeutics 2012-2017E 
    Figure North America 2012-2017E Anti-inflammatory Therapeutics Sales Price (USD/MT)
    Figure North America 2016 Anti-inflammatory Therapeutics Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K MT) of Anti-inflammatory Therapeutics 2012-2017E 
    Figure China 2012-2017E Anti-inflammatory Therapeutics Sales Price (USD/MT) 
    Figure China 2016 Anti-inflammatory Therapeutics Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K MT) of Anti-inflammatory Therapeutics 2012-2017E
    Figure Europe 2012-2017E Anti-inflammatory Therapeutics Sales Price (USD/MT)
    Figure Europe 2016 Anti-inflammatory Therapeutics Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Anti-inflammatory Therapeutics 2012-2017E
    Figure Southeast Asia 2012-2017E Anti-inflammatory Therapeutics Sales Price (USD/MT)
    Figure Southeast Asia 2016 Anti-inflammatory Therapeutics Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K MT) of Anti-inflammatory Therapeutics 2012-2017E
    Figure Japan 2012-2017E Anti-inflammatory Therapeutics Sales Price (USD/MT)
    Figure Japan 2016 Anti-inflammatory Therapeutics Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K MT) of Anti-inflammatory Therapeutics 2012-2017E
    Figure India 2012-2017E Anti-inflammatory Therapeutics Sales Price (USD/MT)
    Figure India 2016 Anti-inflammatory Therapeutics Sales Market Share
    Table Global 2012-2017E Anti-inflammatory Therapeutics Sales (K MT) by Type
    Table Different Types Anti-inflammatory Therapeutics Product Interview Price
    Table Global 2012-2017E Anti-inflammatory Therapeutics Sales (K MT) by Application
    Table Different Application Anti-inflammatory Therapeutics Product Interview Price
    Table AbbVie Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 AbbVie Inc. Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 AbbVie Inc. Anti-inflammatory Therapeutics Business Region Distribution
    Table Pfizer Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Pfizer Inc. Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 Pfizer Inc. Anti-inflammatory Therapeutics Business Region Distribution
    Table Merck & Co., Inc. Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Merck & Co., Inc. Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 Merck & Co., Inc. Anti-inflammatory Therapeutics Business Region Distribution
    Table Johnson & Johnson Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Johnson & Johnson Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 Johnson & Johnson Anti-inflammatory Therapeutics Business Region Distribution
    Table GlaxoSmithKline plc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 GlaxoSmithKline plc Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 GlaxoSmithKline plc Anti-inflammatory Therapeutics Business Region Distribution
    Table AstraZeneca PLC Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 AstraZeneca PLC Anti-inflammatory Therapeutics Business Region Distribution
    Table Amgen Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Amgen Inc Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 Amgen Inc Anti-inflammatory Therapeutics Business Region Distribution
    Table Novartis AG Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Novartis AG Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 Novartis AG Anti-inflammatory Therapeutics Business Region Distribution
    Table F. Hoffmann-La Roche AG Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 F. Hoffmann-La Roche AG Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 F. Hoffmann-La Roche AG Anti-inflammatory Therapeutics Business Region Distribution
    Table Eli Lily and Company Information List
    Table Product A Overview
    Table Product B Overview
    Table 2016 Eli Lily and Company Anti-inflammatory Therapeutics Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2016 Eli Lily and Company Anti-inflammatory Therapeutics Business Region Distribution
    Figure Global 2017-2022 Anti-inflammatory Therapeutics Market Size (K MT) and Growth Rate Forecast
    Figure Global 2017-2022 Anti-inflammatory Therapeutics Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2017-2022 Anti-inflammatory Therapeutics Sales Price (USD/MT) Forecast
    Figure North America 2017-2022 Anti-inflammatory Therapeutics Consumption Volume (K MT) and Growth Rate Forecast
    Figure China 2017-2022 Anti-inflammatory Therapeutics Consumption Volume (K MT) and Growth Rate Forecast
    Figure Europe 2017-2022 Anti-inflammatory Therapeutics Consumption Volume (K MT) and Growth Rate Forecast
    Figure Southeast Asia 2017-2022 Anti-inflammatory Therapeutics Consumption Volume (K MT) and Growth Rate Forecast
    Figure Japan 2017-2022 Anti-inflammatory Therapeutics Consumption Volume (K MT) and Growth Rate Forecast
    Figure India 2017-2022 Anti-inflammatory Therapeutics Consumption Volume (K MT) and Growth Rate Forecast
    Table Global Sales Volume (K MT) of Anti-inflammatory Therapeutics by Type 2017-2022
    Table Global Consumption Volume (K MT) of Anti-inflammatory Therapeutics by Application 2017-2022
    Table Traders or Distributors with Contact Information of Anti-inflammatory Therapeutics by Region



Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...